He received IV PPI, and 2LNS-> with improvement of his HR to 115 while sitting.
Past Medical History: Past Oncologic History: Mr. [**Known lastname 24344**] was diagnosed with melanoma in [**2174**] when he underwent a shave biopsy for an at least 2.6 mm thick and at least [**Doctor Last Name 10834**] level 4 melanoma with focal ulceration and 12 mitosis per high-powered field on the back of his right calf.
He underwent wide local excision at [**Hospital1 2025**] as well as popliteal and 2 inguinal sentinel lymph node biopsies.
He underwent resection of the right thigh mass confirming melanoma and a right pelvic node dissection with no melanoma found in 5 nodes.
He underwent right external pelvic lymph node dissection on [**2178-3-19**].
He received 2 cycles of high-dose interleukin-2 and finished the last cycle on [**2178-7-31**] with a complete response noted.
Routine F/U PET-CT on [**2180-5-2**] revealed disease recurrence in the cervical, supraclavicular and right paracaval regions.
He was evaluated at the NCI Surgery Branch for the adoptive immunotherapy protocol in [**2180-10-25**], requiring two surgeries to obtain TIL's.
PET scan in [**3-5**] documented significant disease progression prior to immunotherapy treatment and he was sent back here to begin chemotherapy.
He received his first cycle of dacarbazine on [**2181-3-23**] with significant nausea and vomiting noted as well as a fever prompting hospital admission on [**2181-4-8**].
It is unclear when the next open slot will be and another cycle of chemotherapy was advised given his symptoms.
*T3B N1A invasive melanoma of the right calf treated w/high-dose interleukin-2, finishing in [**2178-7-25**] and complicated by hypothryroidism and portal vein thrombosis and then compassionate use Ipilipimab protocol on [**5-2**].
Widespread metatstic disease, awaiting stem cell protocol at NIH and chemotherapy trial at UPENN.
Past Surgical History: Wide excision right calf [**6-/2174**] Right groin dissection [**7-/2174**] Pelvic Node dissection, right thigh lesion [**12/2177**] Right pelvic node dissection [**2-/2178**] Exploratory laparotomy and resection of mass at the root of proximal small bowel mesentery [**9-/2179**]  Social History: He works as an administrator at [**Hospital3 1810**].
Heart: RRR no m/r/g Lungs: CTAB no w/r/r Abd: soft NT/ND +BS Ext: wwp, no edema Neuro: CN II-XII in tact, otherwise nonfocal neuro exam Skin: no rash  Pertinent Results: On Admission: [**2181-5-1**] 09:55AM   WBC-23.6*# RBC-3.81* HGB-9.8* HCT-30.0* MCV-79* MCH-25.8* MCHC-32.8 RDW-17.7* [**2181-5-1**] 09:55AM   NEUTS-98* BANDS-0 LYMPHS-0 MONOS-2 EOS-0 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 [**2181-5-1**] 09:55AM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-NORMAL MACROCYT-NORMAL MICROCYT-1+ POLYCHROM-NORMAL [**2181-5-1**] 09:55AM   PLT SMR-VERY HIGH PLT COUNT-634* [**2181-5-1**] 09:55AM   PT-14.3* PTT-22.5 INR(PT)-1.2* [**2181-5-1**] 05:28PM   GLUCOSE-92 UREA N-11 CREAT-0.9 SODIUM-131* POTASSIUM-4.4 CHLORIDE-101 TOTAL CO2-19* ANION GAP-15 [**2181-5-1**] 05:28PM   HCT-29.4* [**2181-5-1**] 02:05PM   HCT-27.6* [**2181-5-1**] 01:00PM   HCT-24.1* .
A posterior nasopharyngeal bleed induced by melanoma could explain his large volume epistaxis and hematemesis.
Decision was made to initiate radiation treatment of nasopharyngeal mass.
After radiation oncology planning and first treatment on [**2181-5-2**], patient received a IR embolization of bilat spheno-palantine branches of maxillary artery without sequelae.
He remained in the MICU overnight on [**2181-5-2**] for monitoring, received boluses for low UOP, but was otherwise stable.
Leukocytosis / Fever - recently started on prednisone 20mg daily on [**2181-4-20**] by [**First Name8 (NamePattern2) 622**] [**Last Name (NamePattern1) 17265**] for severe nausea.
Steroids were continued at current dose.
It improved with blood, fluids and stopping the bleeding source.
It is unclear when the next open slot will be and another cycle of chemotherapy was advised given his symptoms, which was initiated on [**2181-4-20**].
Prophylaxis - iv ppi given evidence of gastritis, pt walking.
Oxycodone 10 mg Tablet Sustained Release 12 hr Sig: One (1) Tablet Sustained Release 12 hr PO Q12H (every 12 hours).
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal [**Hospital1 **] (2 times a day) as needed.
Lactulose 10 gram/15 mL Syrup Sig: Fifteen (15) ML PO Q6H (every 6 hours) as needed.
Percocet 7.5-325 mg Tablet Sig: Two (2) Tablet PO every six (6) hours.
Colace 100 mg Capsule Sig: One (1) Capsule PO three times a day as needed for constipation.
Prochlorperazine Maleate 10 mg Tablet Sig: One (1) Tablet PO  once a day as needed for nausea.
Lorazepam 1 mg Tablet Sig: One (1) Tablet PO four times a day  as needed for nausea.
Oxycodone 10 mg Tablet Sustained Release 12 hr Sig: One (1) Tablet Sustained Release 12 hr PO Q12H (every 12 hours).
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Lactulose 10 gram/15 mL Syrup Sig: Fifteen (15) ML PO DAILY (Daily) as needed for constipation.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Miralax 17 gram (100 %) Powder in Packet Sig: One (1)  PO once a day as needed for constipation.
Ativan 0.5 mg Tablet Sig: 1-2 Tablets PO every six (6) hours as needed for anxiety.
Percocet 7.5-325 mg Tablet Sig: Two (2) Tablet PO four times a day as needed for pain.
Prednisone 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Prochlorperazine Maleate 10 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for nausea for 30 days.
ZOFRAN ODT 8 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, Rapid Dissolve PO three times a day as needed for nausea for 1 months.
